← Every company
Anavex Life Sciences Corp SEC Filings
What Anavex Life Sciences Corp has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
AVXL overview →Filings on file
79
since Dec 14, 2016
Warning signs
4
latest Aug 10, 2026
Last results
Aug 25, 2026
8-K item 2.02
Industry
Biological Products, (No Diagnostic Substances)
SIC 2836
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
| Filed | What it reports | Document |
|---|---|---|
| May 15, 2026 | Executive or director change 8-K | Read ↗ |
| May 6, 2026 | Executive or director change 8-K | Read ↗ |
| Feb 25, 2026 | Executive or director change 8-K | Read ↗ |
| Jul 3, 2025 | Executive or director change 8-K | Read ↗ |
| Jun 13, 2025 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Apr 8, 2022 | Executive or director change 8-K | Read ↗ |
| Mar 4, 2022 | Auditor changeExecutive or director change 8-K | Read ↗ |
| Mar 8, 2018 | Executive or director change 8-K | Read ↗ |
| Oct 6, 2017 | Executive or director change 8-K | Read ↗ |
| Feb 13, 2017 | Executive or director change 8-K | Read ↗ |
Source: Anavex Life Sciences Corp's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.
More on AVXL
Company overviewEverything on AVXL in one place, with the price.Insider tradingWhat AVXL's own officers and directors buy and sell.Who owns itEvery manager reporting a position in AVXL.Funds holding itWhich funds and ETFs hold AVXL, and how big a bet.LobbyingWhat AVXL spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on AVXL's account, and who they worked for.PatentsWhat AVXL is filing at the patent office.